Trial Profile
Phase II open label pilot study of V3381 in chronic cough
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 May 2022
Price :
$35
*
At a glance
- Drugs Indantadol (Primary)
- Indications Cough
- Focus Therapeutic Use
- Sponsors Vernalis
- 02 Nov 2016 New trial record